Figure legends
Fig. 1. Comprehensive spectrum of adverse reactions related to sugammadex reported by VigiBase with positive results from the disproportionate analysis. IC025 > 3 was considered a significant association signal, indicating that the adverse reactions have a strong correlation with sugammadex use.
Fig. 2. Results of the analysis of variance of IC025values of adverse drug reactions in each age group. The ANOVA test showed statistically significant differences (P < 0.01) between age groups, indicating that the overall intensity of adverse reaction signals in the 0–17 years group was the highest.
Fig. 3. Spectrum of adverse drug reactions (ADRs) in different age groups. No signal means no related ADR in this age group or ADR with IC025 < 0.